查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302044

C 反應蛋白檢測市場：按檢測類型、疾病區域、檢測範圍和最終用戶劃分 - COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響 - 2023-2030 年全球預測

C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球 C 反應蛋白檢測市場預計將顯著增長，預計 2030 年將達到 34.254 億美元，預計 2023 年將達到 15.0946 億美元，複合年增長率為 12.39%。

FPNV定位矩陣

FPNV定位矩陣對於評估全球C反應蛋白檢測市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對總收入、客戶群和其他關鍵指標的貢獻，可以讓公司更好地了解他們的表現以及他們在爭奪市場份額時面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4. 市場趨勢：全面了解 COVID-19、俄羅斯-烏克蘭衝突和高通脹的累積影響。

5.競爭評估和信息：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.C反應蛋白檢測的全球市場規模和預測是多少？

2. 在預測期內，COVID-19 對全球 C 反應蛋白檢測市場的抑制因素和影響是什麼？

3. 在預測期內，全球 C 反應蛋白檢測市場需要投資哪些產品/細分市場/應用/領域？

4. 全球C反應蛋白檢測市場的競爭策略是什麼？

5.全球C反應蛋白檢測市場的技術趨勢和監管框架是什麼？

6.全球C反應蛋白檢測市場主要廠商的市場份額是多少？

7.哪些形式和戰略舉措被認為適合進入全球C反應蛋白檢測市場？

目錄

第1章前言

第2章研究方法

第 3 章執行摘要

第4章市場概述

第 5 章市場洞察

  • 市場動態
    • 驅動程序
      • 需要測量各種健康狀況引起的炎症
      • 慢性病發病率上升和老年人口增加
      • 改進 C 反應蛋白的即時檢測，以安全地減少抗生素的使用
    • 抑制因素
      • 提供更多商業化的替代疾病檢測
    • 機會
      • 傳統 CRP 檢測的技術進步
      • C反應蛋白在狗消化系統疾病中的研究
    • 作業
      • 謹慎管理和處理的要求
  • 市場趨勢
  • 新冠肺炎 (COVID-19) 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通脹的累積影響
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制

第 6 章 C 反應蛋白測試市場（按檢測類型）

  • 化學發光免疫分析
    • 免費T3
    • 免費T4
    • 促甲狀腺激素水平
  • □聯免疫吸附試驗
    • 臨床
    • 非臨床
  • 免疫比濁分析
  • 放射免疫分析法
    • 抗促甲狀腺激素受體的自身抗體
    • 人血清甲狀腺球蛋白自身抗體
    • 甲狀腺過氧化物□自身抗體

第7章按疾病領域劃分的C反應蛋白測試市場

  • 癌症
  • 心血管疾病
  • 子宮內膜異位症
  • 炎症性腸病
  • 狼瘡
  • 類風濕性關節炎

第八章C反應蛋白檢測市場按檢測範圍劃分

  • cCRP
  • 傳統 CRP
  • hs-CRP

第 9 章 C 反應蛋白測試市場：按最終用戶劃分

  • 生命支持醫療設施
  • 診所
    • 真實物體
      • 醫生檢查室
      • 小診所
  • 房子
  • 醫院
  • 實驗室

第10章美洲C反應蛋白測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太C反應蛋白測試市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲C反應蛋白測試市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭態勢

  • FPNV定位矩陣
  • 市場份額分析：按主要公司劃分
  • 競爭情景分析：主要公司

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-A339DAEFABE9

The Global C-Reactive Protein Testing Market is forecasted to grow significantly, with a projected USD 1,509.46 million in 2023 at a CAGR of 12.39% and expected to reach a staggering USD 3,425.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global C-Reactive Protein Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global C-Reactive Protein Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Assay Type, market is studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin Levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies. The Radioimmunoassay is projected to witness significant market share during forecast period.

Based on Disease Area, market is studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis. The Endometriosis is projected to witness significant market share during forecast period.

Based on Detection Range, market is studied across cCRP, Conventional CRP, and hs-CRP. The hs-CRP is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratories. The Clinics is further studied across Entity. The Entity is further studied across Physician Offices and Small Clinics. The Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global C-Reactive Protein Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global C-Reactive Protein Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global C-Reactive Protein Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global C-Reactive Protein Testing Market?

4. What is the competitive strategic window for opportunities in the Global C-Reactive Protein Testing Market?

5. What are the technology trends and regulatory frameworks in the Global C-Reactive Protein Testing Market?

6. What is the market share of the leading vendors in the Global C-Reactive Protein Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global C-Reactive Protein Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. C-Reactive Protein Testing Market, by Assay Type, 2022 vs 2030
  • 4.3. C-Reactive Protein Testing Market, by Disease Area, 2022 vs 2030
  • 4.4. C-Reactive Protein Testing Market, by Detection Range, 2022 vs 2030
  • 4.5. C-Reactive Protein Testing Market, by End-User, 2022 vs 2030
  • 4.6. C-Reactive Protein Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
      • 5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
      • 5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotics
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of more commercialized alternative disease testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements pertaining to conventional CRP tests
      • 5.1.3.2. Research on C-reactive protein in gastrointestinal diseases of dogs
    • 5.1.4. Challenges
      • 5.1.4.1. Careful administration and handling requirements
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. C-Reactive Protein Testing Market, by Assay Type

  • 6.1. Introduction
  • 6.2. Chemiluminescence Immunoassay
    • 6.2.1. Free T3
    • 6.2.2. Free T4
    • 6.2.3. Thyrotropin Levels
  • 6.3. ELISA
    • 6.3.1. Clinical
    • 6.3.2. Nonclinical
  • 6.4. Immunoturbidimetric Assay
  • 6.5. Radioimmunoassay
    • 6.5.1. Autoantibodies Against Thyrotropin Receptor
    • 6.5.2. Human Serum Thyroglobulin Autoantibodies
    • 6.5.3. Thyroperoxidase Autoantibodies

7. C-Reactive Protein Testing Market, by Disease Area

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Cardiovascular Diseases
  • 7.4. Endometriosis
  • 7.5. Inflammatory Bowel Disease
  • 7.6. Lupus
  • 7.7. Rheumatoid Arthritis

8. C-Reactive Protein Testing Market, by Detection Range

  • 8.1. Introduction
  • 8.2. cCRP
  • 8.3. Conventional CRP
  • 8.4. hs-CRP

9. C-Reactive Protein Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Assisted Living Healthcare Facilities
  • 9.3. Clinics
    • 9.3.1. Entity
      • 9.3.1.1. Physician Offices
      • 9.3.1.2. Small Clinics
  • 9.4. Home
  • 9.5. Hospitals
  • 9.6. Laboratories

10. Americas C-Reactive Protein Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific C-Reactive Protein Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa C-Reactive Protein Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2022 VS 2030 (%)
  • FIGURE 6. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2022 VS 2030 (%)
  • FIGURE 7. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
  • FIGURE 10. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. C-REACTIVE PROTEIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 6. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN LEVELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 11. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 16. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 21. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 28. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 34. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 36. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)

TA